Author: Kimihiro Tohyama

In the pharmaceutical industry, the cost of clinical research and clinical trials is extremely high, which results in higher drug prices and insurance expenses. Furthermore, the high costs have resulted in decreased numbers of clinical trials at national research institutes and universities, slowing the progress of pharmaceutical research. In addition, incidents of data falsification or […]